• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13D filed by BGM Group Ltd.

    1/6/25 4:30:03 PM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $BGM alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    BGM Group Ltd.

    (Name of Issuer)


    Class A Ordinary Share, par value $0.00833335 per share

    (Title of Class of Securities)


    G7307E123

    (CUSIP Number)


    AIX INC.
    c/o Yinan Hu, 60/F, Pearl River Tower, No. 15 West Zhujiang Road
    Guangzhou, F4, 510623
    86-020-83886888

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    12/27/2024

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    G7307E123


    1 Name of reporting person

    AIX Inc.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    69,995,661.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    69,995,661.00
    11Aggregate amount beneficially owned by each reporting person

    69,995,661.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    72.00 %
    14Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:
    Note to Row 8, 10, 11: Represents 69,995,661 Class A ordinary shares. Note to Row 13: The percentage calculation is based on 97,222,141 ordinary shares, including 77,222,141 Class A ordinary shares and 20,000,000 Class B ordinary shares, of the Issuer outstanding as of December 27, 2024.


    SCHEDULE 13D

    CUSIP No.
    G7307E123


    1 Name of reporting person

    CISG Holdings Ltd.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    VIRGIN ISLANDS, BRITISH
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    69,995,661.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    69,995,661.00
    11Aggregate amount beneficially owned by each reporting person

    69,995,661.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    72.00 %
    14Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:
    Note to Row 8, 10, 11: Represents 69,995,661 Class A ordinary shares. Note to Row 13: The percentage calculation is based on 97,222,141 ordinary shares, including 77,222,141 Class A ordinary shares and 20,000,000 Class B ordinary shares, of the Issuer outstanding as of December 27, 2024.


    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Class A Ordinary Share, par value $0.00833335 per share
    (b)Name of Issuer:

    BGM Group Ltd.
    (c)Address of Issuer's Principal Executive Offices:

    No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District, Chengdu, CHINA , 610200.
    Item 2.Identity and Background
    (a)
    This Schedule 13D is being filed jointly by AIX Inc. ("AIX") and CISG Holdings Ltd. ("CISG") (each, a "Reporting Person" and together, the "Reporting Persons") pursuant to Rule 13d-1(k) promulgated by the SEC under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). CISG is 100% held by AIX.
    (b)
    The principal business and office address of AIX is 60F, Pearl River Tower, No. 15 West Zhujiang Road, Zhujiang New Town, Tianhe, Guangzhou, Guangdong Province, People's Republic of China. The registered address of CISG is Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands.
    (c)
    AIX is a holding company whose ordinary shares, represented by ADSs, are listed on the Nasdaq Global Select Market. Through its various subsidiaries and affiliated entities, AIX operates as a leading technology-driven independent financial service provider in China. CISG is a holding company without any substantive operations.
    (d)
    During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
    (e)
    During the last five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, is or was subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such law
    (f)
    AIX is an exempt company with limited liability incorporated under the laws of Cayman Islands. CISG is an exempt company with limited liability incorporated under the laws of British Virgin Island.
    Item 3.Source and Amount of Funds or Other Consideration
     
    On November 27, 2024 CISG entered into a transaction agreement (the "Agreement") with BMG. Pursuant to the Agreement, CISG agreed to transfer the equity interests of its AI insurance platform including RONS Intelligent Technology (Beijing) Co., Ltd. ("RONS Technology"), Shenzhen Xinbao Investment Management Co., Ltd. ("Xinbao Investment"), and Xinbao Investment's wholly-owned subsidiaires RONS Insurance Sales & Service Co., Ltd. and Shenzhen Baowang E-commerce Co., Ltd., in exchange for 69,995,661 Class A ordinary shares of BGM equal to approximately US$140,000,000 (the "Transaction"). The Transaction has been completed on December 27, 2024, following which AIX, through CISG, beneficially owns 69,995,661 Class A ordinary shares of BGM, representing 72% of the total ordinary shares outstanding and 3.4% of the voting power of the Issuer. The Agreement has been filed by AIX with the SEC as Exhibit 99.1 to Form 6-K on November 29, 2024, which is hereby incorporated by reference.
    Item 4.Purpose of Transaction
     
    The information set forth in Item 3 is hereby incorporated by reference. The Reporting Persons acquired beneficial ownership of the Ordinary Shares as described in this Schedule 13D for investment purposes. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Each Reporting Person may in the future take such actions with respect to its investment in the Issuer as it deems appropriate, including changing its current intentions, with respect to any or all matters required to be disclosed in this Schedule 13D, depending on various factors, including but not limited to the Issuer's business, prospects, financial position and strategic direction, price levels of the ADSs, conditions in the securities markets, and general economic and industry conditions. Consistent with the Reporting Persons' investment purposes, the Reporting Persons may engage in communications with, without limitation, one or more shareholders of the Issuer, management of the Issuer or one or more members of the board of directors of the Issuer, and may make suggestions concerning the Issuer's operations, prospects, business and financial strategies, strategic direction and transactions, assets and liabilities, business and financing alternatives and such other matters as the Reporting Persons may deem relevant to their investment in the Ordinary Shares. The Reporting Persons expect that they will, from time to time, review their investment position in the Issuer and may make additional purchases of Ordinary Shares (or other securities convertible or exercisable into Ordinary Shares) in the open market or in privately negotiated transactions, or hold or dispose of all or part of their investments in the Ordinary Shares, depending upon the Reporting Persons' evaluation of the Issuer's business, prospects, financial condition and strategic direction, the market for the ADSs, other opportunities available to the Reporting Persons, general economic conditions, stock market conditions and other factors. Except as set forth in this Item 4 or Item 6 below, the Reporting Persons have no present plans or proposals that relate to or that would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D of the Act.
    Item 5.Interest in Securities of the Issuer
    (a)
    The aggregate number of ordinary shares benefically owned by the Reporting Persons is 69,995,661, representing 69,995,661 Class A ordinary shares of the Issuer directly held by CISG which is 100% held by AIX. Pursuant to Section 13(d) of the Exchange Act and the rules promulgated thereunder, AIX may be deemed to beneficially own all of the Class A ordinary shares of the Issuer held by CISG. The Reporting Persons' aggregate percentage of beneficial ownership is 72.00%, representing 3.4% of the voting power of the Issuer. Percentage of beneficial ownership of each Reporting Person is based on 97,222,141 ordinary shares outstanding as of December 27, 2024, including 77,222,141 Class A ordinary shares and 20,000,000 Class B ordinary shares. Each Class A ordinary share is entitled to one (1) vote while each Class B ordinary share is entitled to one hundred (100) votes on any and all matters submitted for a vote.
    (b)
    Each of the Reporting Persons has shared voting and dispositive power over the ordinary shares of reported in this Schedule 13D.
    (c)
    During the 60 days preceding the filing of this Schedule 13D, none of the Reporting Persons and, to their knowledge, none of the director and officer of the Reporting Persons has effected any transactions in the Ordinary Shares of the Issuer except as reported herein.
    (d)
    To the best knowledge of the Reporting Persons, except for the agreement described in this Schedule 13D, no one other than the Reporting Persons, or the holders of interests in the Reporting Persons, has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Ordinary Shares of the Issuer that they beneficially own.
    (e)
    Not applicable.
    Item 6.Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
     
    Except as described above or elsewhere in this Statement or incorporated by reference in this Statement, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Person and between the Reporting Persons and any person with respect to any securities of the Company, including, but not limited to, transfer or voting of any securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies.
    Item 7.Material to be Filed as Exhibits.
     
    Exhibit 1: Joint Filing Agreement dated January 6, 2025 by and between the Reporting Persons Exhibit 2: List of directors and executive officers of (i) AIX Inc. and (ii) CISG Holdings Inc. (filed herewith) Exhibit 3: Transaction Agreement dated as of November 27, 2024, entered and made among BGM Group Ltd., CISG Holdings Ltd., Patriton Limited, GM Management Company Limited, Duxiaobao Intelligent Technology (Shenzhen) Co., Ltd., RONS Intelligent Technology (Beijing) Co., (incorporated by reference to Exhibit 99.3 to the Form 6-K filed with the Securities and Exchange Commission by AIX Inc. on November 29, 2024)

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    AIX Inc.
     
    Signature:/s/ Yinan Hu
    Name/Title:Yinan Hu/Director
    Date:01/06/2025
     
    CISG Holdings Ltd.
     
    Signature:/s/ Yinan Hu
    Name/Title:Yinan Hu/Director
    Date:01/06/2025
    Get the next $BGM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BGM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BGM
    SEC Filings

    View All

    SEC Form NT 20-F filed by BGM Group Ltd.

    NT 20-F - BGM Group Ltd. (0001779578) (Filer)

    1/30/26 4:30:13 PM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by BGM Group Ltd.

    6-K - BGM Group Ltd. (0001779578) (Filer)

    1/29/26 8:27:49 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by BGM Group Ltd.

    6-K - BGM Group Ltd. (0001779578) (Filer)

    12/22/25 7:00:19 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BGM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BGM To Report First Half 2025 Unaudited Financial Results on July 24, 2025

    CHENGDU, China, July 23, 2025 /PRNewswire/ -- BGM Group (the "Company" or "BGM") (NASDAQ:BGM) today announced that it will release its unaudited financial results for the first half 2025 before the U.S. financial markets open on July 24, 2025 Eastern Daylight Time. About BGM  BGM Group Ltd. has a strategic focus on the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. In terms of AI application implementation, the group relies on advanced analytics and AI Agent technology, and utilizes the two platforms of Du Xiao Bao and Bao Wang to provide comprehensive and professional AI solutions and intelligent robot services

    7/23/25 6:36:00 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts

    CHENGDU, China, May 28, 2025 /PRNewswire/ -- BGM Group Ltd. (the "Company" or BGM)  (NASDAQ:BGM) today announced that it has entered into definitive transaction agreements with the existing shareholders of Xingdao Intelligent Cloud Chain (Shenzhen) Co., Ltd. ("Xingdao Intelligent") and YD Network Technology Company Limited ("YD Network"). Under the terms of the agreements, BGM will acquire 100% of the equity interests of both companies at a combined valuation of RMB800 million. The consideration will be paid through the issuance of 37,123,142 newly issued Class A ordinary shares of BGM at a price of US$3.0 per share. The transactions are expected to close by the end of June 2025, subject to

    5/28/25 4:30:00 PM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BGM Group Announces Strategic Acquisition of HM Management to Expand AI Application Ecosystem

    CHENGDU, China, May 2, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) (the "Company" or "BGM") , a leading AI technology company, today announced it has entered into a definitive agreement (the "Agreement") to acquire HM Management Company Limited ("HM Management"), a prominent AI agent production platform, in an all-stock transaction valued at approximately RMB300 million (US$41.7 million). Under the Agreement, BGM will issue 16,663,427 Class A ordinary shares at $2.50 per share to acquire 100% ownership of HM Management and its two wholly-owned subsidiaries: Beijing Shuda Technology Company Limited. ("Shuda Technology") and New Media Star Technology (Shenzhen) Co., Ltd ( "New Media Star

    5/2/25 8:30:00 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BGM
    Leadership Updates

    Live Leadership Updates

    View All

    BGM Group Announces Board Reshuffle: New Leadership Embarks on a Transformative Journey Amid Tech Revolution

    CHENGDU, China, Feb. 28, 2025 /PRNewswire/ -- BGM Group Ltd (NASDAQ:BGM) (the "Company" or "BGM") today announced changes to its board of directors, marking the Company's entry into a new phase of technological transformation and sustainable growth. Mr. Zhanchang Xin has tendered his resignation and will step down from his role as Chairman of the Company, effective March 1, 2025. He will be succeeded by Mr. Chen Xin, the current Chief Executive Officer of the Company, who will assume the position of Chairman. As the founder of the Company, Mr. Zhanchang Xin has, over the past six decades, has played a pivotal role in leading the Company through numerous challenges and milestones, including

    2/28/25 8:30:00 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BGM Group Establishes "Duxiaobao Management Committee" to Accelerate AI Strategy and Drive Intelligent Transformation in the Insurance Industry

    CHENGDU, China, Feb. 19, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) announced the establishment of the "Duxiaobao Management Committee," which will be fully responsible for the management and decision-making of the "Duxiaobao" ecosystem. This move signifies BGM Group's strategic entry into the field of artificial intelligence, aiming to accelerate the transformation of the insurance industry into the smart era through AI technology. The Duxiaobao Management Committee consists of industry leaders such as Xin Chen, Li Yuqing, Ge Peng, Zhao Qi, Ren Yong, Li Jun, Zhou Xin, and Wang Hui. The committee has appointed Li Yuqing as the CEO of Duxiaobao, with Li Jun, Ren Yong, Zhou Xin, and Tan

    2/19/25 7:30:00 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BGM
    Financials

    Live finance-specific insights

    View All

    From Virtual Agents to Embodied and Industry-Specific AI: BGM Acquires Xingdao Intelligent and YD Network, Advancing AI on Two Fronts

    CHENGDU, China, May 28, 2025 /PRNewswire/ -- BGM Group Ltd. (the "Company" or BGM)  (NASDAQ:BGM) today announced that it has entered into definitive transaction agreements with the existing shareholders of Xingdao Intelligent Cloud Chain (Shenzhen) Co., Ltd. ("Xingdao Intelligent") and YD Network Technology Company Limited ("YD Network"). Under the terms of the agreements, BGM will acquire 100% of the equity interests of both companies at a combined valuation of RMB800 million. The consideration will be paid through the issuance of 37,123,142 newly issued Class A ordinary shares of BGM at a price of US$3.0 per share. The transactions are expected to close by the end of June 2025, subject to

    5/28/25 4:30:00 PM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BGM Group Acquires Wonder Dragon to Accelerate "Healthcare" Strategy

    CHENGDU, China, April 21, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ:BGM) today announced that it has signed a definitive transaction agreement with the existing shareholders of Wonder Dragon Global Limited ("Wonder Dragon"), to acquire 100% of the equity interests of Wonder Dragon by issuing 38,165,290 Class A ordinary shares at a price of $2 per share, for a total transaction valuation of RMB550 million. The transaction is expected to be completed in the second quarter of 2025. Wonder Dragon possesses over 3,000 metric tons of premium Qingzhuan dark tea inventory, comprising 1,670 metric tons of raw materials and 1,350 metric tons of finished products. These premium tea products, known f

    4/21/25 8:30:00 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BGM Acquires YX to Strengthen AI Strategy for Its Intelligent Platform

    CHENGDU, China, March 19, 2025 /PRNewswire/ -- BGM Group Ltd. (the "Company" or BGM) (NASDAQ:BGM) today announced that it has signed a definitive agreement with the existing shareholders of YX Management Company Ltd. ("YX"), a smart mobility technology company. Under the agreement, BGM will acquire 100% of the equity interests of YX by issuing 47.5 million class A ordinary shares to its existing shareholders, valuing YX at US$95.0 million. This acquisition is based on the exceptional expertise and experience of the YX team in scalable operations, digital infrastructure development, and technology commercialization. The integration of this team will accelerate the AI-driven strategic upgrade

    3/19/25 8:30:00 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BGM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by BGM Group Ltd.

    SC 13D - BGM Group Ltd. (0001779578) (Subject)

    12/3/24 6:03:06 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by BGM Group Ltd.

    SC 13D/A - BGM Group Ltd. (0001779578) (Subject)

    11/29/24 9:00:27 AM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13D filed by Qilian International Holding Group Ltd.

    SC 13D - Qilian International Holding Group Ltd (0001779578) (Subject)

    10/16/24 4:19:46 PM ET
    $BGM
    Biotechnology: Pharmaceutical Preparations
    Health Care